MBINL Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher Viant DSP Reports Mixed Q1 2026 Revenue Beats but EPS Misses Mistras Group MG Crushes Q1 2026 Estimates EPS 008 Tops Views Tecogen Inc TGEN Q1 2026 Earnings EPS Beat Estimates Stock Rises Brookings Analysis Potential ShortRun Economic Impacts of 2025 Tariffs on US Economy Genpact CEO Warns of AIDriven Reduction in IT Workload and Jobs Indias Peak Power Demand Reaches 26745 GW on Friday Narrowly Below AllTime High Silicon Valleys New Target Unsexy LowMargin Industries UK Labours Capital Gains Tax Proposal Implications for Investors and Markets Matthieu Pigasse The Socialist Banker Venezuela Tapped to Restructure Finances and Lure Investors VSTS Q1 2026 Earnings Massive EPS Beat Drives Investor Scrutiny Amid Revenue Discretion CHYM Q1 2026 Earnings Strong EPS Surprise Amidst Stock Pullback GWAV Q3 2023 Earnings Negative EPS Reported Stock Rises 225 Via Transportation Inc VIA Q1 2026 Earnings EPS Beat Exceeds Estimates by 1319 Biogen Q1 2026 Earnings Strong EPS Surprise of 2634 Boosts Investor Confidence Diageo DEO Q1 2026 Earnings EPS Misses Estimates as Spirits Demand Softens Globally Marygold Companies MGLD Edges Lower Amid Light Trading Key Support in Focus Geo Group Inc GEO Declines 36 as Stock Tests Key Support Area ACI Worldwide ACIW Inches Higher Amid Consolidation Key Levels in Focus Intercorp Financial Services IFS Edges Lower by 087 as Stock Approaches Support Zone Legence Corp LGN Edges Higher as Stock Holds Above Key Support Patria Investments PAX Slips 134 as Stock Holds Above Key Support IPG Photonics IPGP Under Pressure Analyzing the 236 Slide and Key Levels Fate Therapeutics Rallies 95 as FATE Stock Breaks Above Key Support Level Chemomab Therapeutics CMMB Stages a Sharp Rebound Can the Biotech Sustain Its Upward Momentum Cohen Steers ClosedEnd Opportunity Fund FOF Edges Higher Key Levels in Focus Kinetik Holdings KNTK Slips 287 Support Test Looms as Energy Midstream Faces Pressure GitHubs AI Coding Ambitions Hampered by Outages and Rising Competition CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline Solo Brands Inc SBDS Slides Modestly Amid Broader Market Pressure